Sho Iketani

Jan 14, 2025 | biorxiv.org | Kazuya Masuda |Sho Iketani |Lihong Liu |Jing Huang

AbstractAlthough emerging data have revealed the critical role of memory CD8+ T cells in preventing and controlling SARS-CoV-2 infection, virus-specific CD8+ T-cell responses against SARS-CoV-2 and its memory and innate-like subsets in unvaccinated COVID-19 patients with various disease manifestations in an HLA-restricted fashion remain to be understood.

May 29, 2024 | digitalcommons.library.tmc.edu | Qian Wang |Yicheng Guo |Sho Iketani |Manoj Nair

Home > UTHealth > McGovern Medical School > Journal Articles > 799 Antibodies, Neutralizing, Antibodies, Viral, Antigenic Drift and Shift, COVID-19, COVID-19 Vaccines, Humans, Immunization, Secondary, Mutation, Receptors, Virus, SARS-CoV-2, Spike Glycoprotein, Coronavirus DOWNLOADS COinS...

Oct 23, 2023 | nature.com | Yicheng Guo |Liyuan Liu |Manoj Nair |Sho Iketani |Yiming Huang |Adam S. Lauring | +3 more

AbstractA SARS-CoV-2 Omicron subvariant, BA.2.86, has emerged and spread to numerous countries worldwide, raising alarm because its spike protein contains 34 additional mutations compared to its BA.2 predecessor1. We examined its antigenicity using human sera and monoclonal antibodies (mAbs). Reassuringly, BA.2.86 was not more resistant to human sera than the currently dominant XBB.1.5 and EG.5.1, indicating that the new subvariant would not have a growth advantage in this regard.